PERSPECTA

News from every angle

← Back to headlines

3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds

23 Feb, 10:30 — 23 Feb, 10:30
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo12h ago

3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds

Read full article →

Related Stories

Vir Biotechnology GAAP EPS of -$0.31 beats by $0.10, revenue of $64.07M beats by $44.16M

1m ago

Market Narratives Drive Stock Decline

1m ago

Keurig Dr Pepper updates financing plan for JDE Peet

11m ago

ORIC Pharmaceuticals Reports GAAP EPS of -$0.30, Beating Estimates

11m ago